- Home
- FLNG vs XERS Comparison
FLNG vs XERS Comparison
Compare FLNG & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNG
- XERS
- Stock Information
- Founded
- FLNG 2006
- XERS 2005
- Country
- FLNG Bermuda
- XERS United States
- Employees
- FLNG N/A
- XERS N/A
- Industry
- FLNG Marine Transportation
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- FLNG Consumer Discretionary
- XERS Health Care
- Exchange
- FLNG Nasdaq
- XERS Nasdaq
- Market Cap
- FLNG 1.3B
- XERS 1.3B
- IPO Year
- FLNG N/A
- XERS 2018
- Fundamental
- Price
- FLNG $25.65
- XERS $9.57
- Analyst Decision
- FLNG Hold
- XERS Strong Buy
- Analyst Count
- FLNG 1
- XERS 7
- Target Price
- FLNG $23.00
- XERS $8.00
- AVG Volume (30 Days)
- FLNG 307.3K
- XERS 2.3M
- Earning Date
- FLNG 11-12-2025
- XERS 11-06-2025
- Dividend Yield
- FLNG 11.68%
- XERS N/A
- EPS Growth
- FLNG N/A
- XERS N/A
- EPS
- FLNG 1.83
- XERS N/A
- Revenue
- FLNG $355,837,000.00
- XERS $246,025,000.00
- Revenue This Year
- FLNG N/A
- XERS $43.89
- Revenue Next Year
- FLNG $2.47
- XERS $20.40
- P/E Ratio
- FLNG $14.04
- XERS N/A
- Revenue Growth
- FLNG N/A
- XERS 35.62
- 52 Week Low
- FLNG $19.46
- XERS $2.82
- 52 Week High
- FLNG $27.67
- XERS $10.03
- Technical
- Relative Strength Index (RSI)
- FLNG 55.63
- XERS 68.59
- Support Level
- FLNG $24.70
- XERS $9.11
- Resistance Level
- FLNG $26.19
- XERS $10.03
- Average True Range (ATR)
- FLNG 0.54
- XERS 0.40
- MACD
- FLNG 0.10
- XERS 0.04
- Stochastic Oscillator
- FLNG 75.34
- XERS 79.78
About FLNG FLEX LNG Ltd.
Flex LNG Ltd is an LNG shipping company with a fleet of next-generation LNG carriers with large cargo capacity. The fleet consists of thirteen modern LNG ships, ten existing and three under construction for delivery. All LNG carriers are equipped with slow-speed, two-stroke engines MEGI or X-DF propulsion which will provide Charterers with tonnage offering advantages in form of reduced fuel consumption and lowered boil-off rates.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).